Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fecal Microbiota Transplantation Combined with Peginterferon for Chronic Hepatitis B
ChiCTR2600126530Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital, Anhui Medical University
- Start
- Jun 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of pegylated interferon alpha in Chronic Hepatitis B (CHB) (2 arms), sponsored by The First Affiliated Hospital, Anhui Medical University. Primary endpoints: HBsAg seroconversion rate and HBsAb level at 72 weeks, Liver fibrosis level at 72 weeks and 1 more. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
pegylated interferon alpha
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR2600126530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600126530.